NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and CFO Glenn Goddard sold $3.0M of Intellia Therapeutics, Inc.
Sold$3,021,056
$151.05Price
20,000Shares
−100%Stake
What NTLA did after the filing
- The stock from Fri, Aug 6 close, $167.31
- −11.3%
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Sep 20 close.
Traded Thu, Aug 5. Filed Fri, Aug 6, 2:17 PM ET, during the session. Returns use the Aug 6 close and the Sep 20 close. Not investment advice.